Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Hypoparathyroidism, Date of authorisation: 24/04/2017, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Vomiting;Neoplasms;Nausea;Cancer, Date of authorisation: 27/05/2015, Revision: 16, Status: Authorised
Flurbiprofen : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001450/202211
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Idiopathic Pulmonary Fibrosis;Lung Diseases;Respiratory Tract Diseases, Date of authorisation: 27/02/2011, Revision: 33, Status: Authorised
Applications for new human medicines under evaluation by the CHMP: September 2023
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Migraine Disorders, Date of authorisation: 14/11/2018, Revision: 10, Status: Authorised
Clinical investigation of medicinal products in the treatment of depression - Scientific guideline
Referral: Synapse, Article 31 referrals, Procedure started, 07/09/2023
Application form for European Medicines Agency certificates of medicinal products
EVVET – Data warehouse user manual